Promoter hypermethylation of SHOX2 and SEPT9 is a potential biomarker for minimally invasive diagnosis in adenocarcinomas of the biliary tract
Crossref DOI link: https://doi.org/10.1186/s13148-016-0299-x
Published Online: 2016-12-12
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Branchi, V.
Schaefer, P.
Semaan, A.
Kania, A.
Lingohr, P.
Kalff, J. C.
Schäfer, N.
Kristiansen, G.
Dietrich, D.
Matthaei, H.
Funding for this research was provided by:
Bonn University Medical Faculty ((O-112005))
